Biotechnology company Aptamer Group has launched a radiopharmaceutical programme to develop new therapeutic targets. The programme, launched in collaboration with Radiopharmium, will look to develop three strategic...
The new issue of DDW is now on its way to subscribers and available to read online. The Spring issue explores the next phase of obesity medications...
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.
From Microbes to Materials—ZymoChem's Vision for a Plastic-Free FutureZymoChem's Vision for a Plastic-Free Future
Nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore.
Nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.
Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem.
Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et.